Correction: "The cellular factor NXP2/MORC3 is a positive regulator of influenza virus multiplication" [Journal of Virology, 89, 19, (2015), (10023-10030)] doi: 10.1128/JVI.01530-15;The cellular factor NXP2/MORC3 is a positive regulator of influenza virus multiplication

Journal of Virology

Volumn 89, Issue 19, 2015, Pages 10023-10030

  Ver, Lorena S ^a,b,c   Marcos Villar, Laura ^a,b   Landeras Bueno, Sara ^a,b   Nieto, Amelia ^a,b   Ortín, Juan ^a,b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; MESSENGER RNA; MORC3 PROTEIN; NXP2 PROTEIN; REGULATOR PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; MORC3 PROTEIN, HUMAN; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CAT GENE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLUENZA; INFLUENZA VIRUS; MORC3 GENE; NONHUMAN; NXP2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REGULATOR GENE; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; VIRUS TRANSCRIPTION; ANTAGONISTS AND INHIBITORS; CELL LINE; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); METABOLISM; PATHOGENICITY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATASES; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; PROTEOMICS; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84940990571     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01757-17     Document Type: Erratum

References (58)

1. Palese P, Shaw M. 2013. Orthomyxoviridae, 6th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Vasin AV, Temkina OA, Egorov VV, Klotchenko SA, Plotnikova MA, Kiselev OI. 2014. Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins. Virus Res 185:53-63. http://dx.doi.org/10.1016/j.virusres.2014.03.015.
3. Arranz R, Coloma R, Chichon FJ, Conesa JJ, Carrascosa JL, Valpuesta JM, Ortin J, Martin-Benito J. 2012. The structure of native influenza virion ribonucleoproteins. Science 338:1634-1637. http://dx.doi.org/10.1126/science.1228172.
4. Martin-Benito J, Ortin J. 2013. Influenza virus transcription and replication. Adv Virus Res 87:113-137. http://dx.doi.org/10.1016/B978-0-12-407698-3.00004-1.
5. Resa-Infante P, Jorba N, Coloma R, Ortin J. 2011. The influenza virus RNA synthesis machine: advances in its structure and function. RNA Biol 8:207-215. http://dx.doi.org/10.4161/rna.8.2.14513.
6. Fodor E. 2013. The RNA polymerase of influenza A virus: mechanisms of viral transcription and replication. Acta Virol 57:113-122. http://dx.doi.org/10.4149/av_2013_02_113.
7. Eisfeld AJ, Neumann G, Kawaoka Y. 2015. At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol 13:28-41. http://dx.doi.org/10.1038/nrmicro3367.
8. Matsuoka Y, Matsumae H, Katoh M, Eisfeld AJ, Neumann G, Hase T, Ghosh S, Shoemaker JE, Lopes TJ, Watanabe T, Watanabe S, Fukuyama S, Kitano H, Kawaoka Y. 2013. A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol 7:97. http://dx.doi.org/10.1186/1752-0509-7-97.
9. Naffakh N, Tomoiu A, Rameix-Welti MA, van der Werf S. 2008. Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu Rev Microbiol 62:403-424. http://dx.doi.org/10.1146/annurev.micro.62.081307.162746.
10. Nagata K, Kawaguchi A, Naito T. 2008. Host factors for replication and transcription of the influenza virus genome. Rev Med Virol 18:247-260. http://dx.doi.org/10.1002/rmv.575.
11. Jorba N, Juarez S, Torreira E, Gastaminza P, Zamarreno N, Albar JP, Ortin J. 2008. Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 8:2077-2088. http://dx.doi.org/10.1002/pmic.200700508.
12. Jackson DA, Caton AJ, McCready SJ, Cook PR. 1982. Influenza virus RNA is synthesized at fixed sites in the nucleus. Nature 296:366-368. http://dx.doi.org/10.1038/296366a0.
13. Lopez-Turiso JA, Martinez C, Tanaka T, Ortin J. 1990. The synthesis of influenza virus negative-strand RNA takes place in insoluble complexes present in the nuclear matrix fraction. Virus Res 16:325-337. http://dx.doi.org/10.1016/0168-1702(90)90056-H.
14. Li DQ, Nair SS, Kumar R. 2013. The MORC family: new epigenetic regulators of transcription andDNAdamage response. Epigenetics 8:685-693. http://dx.doi.org/10.4161/epi.24976.
15. Kimura Y, Sakai F, Nakano O, Kisaki O, Sugimoto H, Sawamura T, Sadano H, Osumi T. 2002. The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains. J Biol Chem 277:20611-20617. http://dx.doi.org/10.1074/jbc. M201440200.
16. Dutta R, Inouye M. 2000. GHKL, an emergent ATPase/kinase superfamily. Trends Biochem Sci 25:24-28. http://dx.doi.org/10.1016/S0968-0004(99)01503-0.
17. Perry J, Zhao Y. 2003. The CW domain, a structural module shared amongst vertebrates, vertebrate-infecting parasites and higher plants. Trends Biochem Sci 28:576-580. http://dx.doi.org/10.1016/j.tibs.2003.09.007.
18. Inoue N, Hess KD, Moreadith RW, Richardson LL, Handel MA, Watson ML, Zinn AR. 1999. New gene family defined by MORC, a nuclear protein required for mouse spermatogenesis. Hum Mol Genet 8:1201-1207. http://dx.doi.org/10.1093/hmg/8.7.1201.
19. Takahashi K, Yoshida N, Murakami N, Kawata K, Ishizaki H, Tanaka-Okamoto M, Miyoshi J, Zinn AR, Shime H, Inoue N. 2007. Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol Biol Cell 18:1701-1709. http://dx.doi.org/10.1091/mbc. E06-08-0747.
20. Mimura Y, Takahashi K, Kawata K, Akazawa T, Inoue N. 2010. Twostep colocalization of MORC3 with PML nuclear bodies. J Cell Sci 123: 2014-2024. http://dx.doi.org/10.1242/jcs.063586.
21. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de The H. 1998. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72:1043-1051.
22. Geoffroy MC, Chelbi-Alix MK. 2011. Role of promyelocytic leukemia protein in host antiviral defense. J Interferon Cytokine Res 31:145-158. http://dx.doi.org/10.1089/jir.2010.0111.
23. Ortin J, Najera R, Lopez C, Davila M, Domingo E. 1980. Genetic variability of Hong Kong (H3N2) influenza viruses: spontaneous mutations and their location in the viral genome. Gene 11:319-331. http://dx.doi.org/10.1016/0378-1119(80)90072-4.
24. Tobita K, Sugiura A, Enomote C, Furuyama M. 1975. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol 162:9-14. http://dx.doi.org/10.1007/BF02123572.
25. Aparicio O, Razquin N, Zaratiegui M, Narvaiza I, Fortes P. 2006. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. J Virol 80:1376-1384. http://dx.doi.org/10.1128/JVI.80.3.1376-1384.2006.
26. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463-8471.
27. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501. http://dx.doi.org/10.1261/rna.2192803.
28. Falcon AM, Marion RM, Zurcher T, Gomez P, Portela A, Nieto A, Ortin J. 2004. Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol 78:3880-3888. http://dx.doi.org/10.1128/JVI.78.8.3880-3888.2004.
29. Llompart CM, Nieto A, Rodriguez-Frandsen A. 2014. Specific residues of PB2 and PA influenza virus polymerase subunits confer the ability for RNA polymerase II degradation and virus pathogenicity in mice. J Virol 88:3455-3463. http://dx.doi.org/10.1128/JVI.02263-13.
30. Levitz SM, Diamond RD. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis 152:938-945. http://dx.doi.org/10.1093/infdis/152.5.938.
31. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671-675. http://dx.doi.org/10.1038/nmeth.2089.
33. Barcena J, Ochoa M, de la Luna S, Melero JA, Nieto A, Ortin J, Portela A. 1994. Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viralmRNAsynthesis in vitro. J Virol 68:6900-6909.
34. Ochoa M, Barcena J, de la Luna S, Melero JA, Douglas AR, Nieto A, Ortin J, Skehel JJ, Portela A. 1995. Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides. Virus Res 37:305-315. http://dx.doi.org/10.1016/0168-1702(95)00039-S.
35. Gonzalez S, Ortin J. 1999. Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. J Virol 73:631-637.
36. Coloma R, Valpuesta JM, Arranz R, Carrascosa JL, Ortin J, Martin-Benito J. 2009. The structure of a biologically active influenza virus ribonucleoprotein complex. PLoS Pathog 5:e1000491. http://dx.doi.org/10.1371/journal.ppat.1000491.
37. Landeras-Bueno S, Jorba N, Perez-Cidoncha M, Ortin J. 2011. The splicing factor proline-glutamine rich (SFPQ/PSF) is involved in influenza virus transcription. PLoS Pathog 7:e1002397. http://dx.doi.org/10.1371/journal.ppat.1002397.
38. Nin N, Lorente JA, Sanchez-Rodriguez C, Granados R, Ver LS, Soto L, Hidalgo J, Fernandez-Segoviano P, Ortin J, Esteban A. 2011. Kidney histopathological findings in fatal pandemic 2009 influenza A (H1N1). Intensive Care Med 37:880-881. http://dx.doi.org/10.1007/s00134-011-2183-7.
39. Rodriguez A, Perez-Gonzalez A, Nieto A. 2007. Influenza virus infection causes specific degradation of the largest subunit of cellularRNApolymerase II. J Virol 81:5315-5324. http://dx.doi.org/10.1128/JVI.02129-06.
40. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213-232. http://dx.doi.org/10.1111/j.1365-2818.2006.01706.x.
41. Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S. 2004. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 86:3993-4003. http://dx.doi.org/10.1529/biophysj.103.038422.
42. van Steensel B, van Binnendijk EP, Hornsby CD, van der Voort HT, Krozowski ZS, de Kloet ER, van Driel R. 1996. Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J Cell Sci 109:787-792.
43. Jorba N, Coloma R, Ortin J. 2009. Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication. PLoS Pathog 5:e1000462. http://dx.doi.org/10.1371/journal.ppat.1000462.
44. Wigler M, Pellicer A, Silverstein S, Axel R, Urlaub G, Chasin L. 1979. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A 76:1373-1376. http://dx.doi.org/10.1073/pnas.76.3.1373.
45. Kawakami E, Watanabe T, Fujii K, Goto H, Watanabe S, Noda T, Kawaoka Y. 2011. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J Virol Methods 173:1-6. http://dx.doi.org/10.1016/j.jviromet.2010.12.014.
46. Alfonso R, Lutz T, Rodriguez A, Chavez JP, Rodriguez P, Gutierrez S, Nieto A. 2011. CHD6 chromatin remodeler is a negative modulator of influenza virus replication that relocates to inactive chromatin upon infection. Cell Microbiol 13:1894-1906. http://dx.doi.org/10.1111/j.1462-5822.2011.01679.x.
47. Engelhardt OG, Fodor E. 2006. Functional association between viral and cellular transcription during influenza virus infection. Rev Med Virol 16: 329-345. http://dx.doi.org/10.1002/rmv.512.
48. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, Maurer AP, Muller E, WolffT, Rudel T, Meyer TF. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-822. http://dx.doi.org/10.1038/nature08760.
49. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, Garcia-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK. 2010. Human host factors required for influenza virus replication. Nature 463:813-817. http://dx.doi.org/10.1038/nature08699.
50. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267. http://dx.doi.org/10.1016/j.cell.2009.12.018.
51. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenzaAH1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
52. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y. 2008. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454:890-893. http://dx.doi.org/10.1038/nature07151.
53. Bortz E, Westera L, Maamary J, Steel J, Albrecht RA, Manicassamy B, Chase G, Martinez-Sobrido L, Schwemmle M, Garcia-Sastre A. 2011. Host-and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. mBio 2:e00151-11. http://dx.doi.org/10.1128/mBio.00151-11.
54. Mayer D, Molawi K, Martinez-Sobrido L, Ghanem A, Thomas S, Baginsky S, Grossmann J, Garcia-Sastre A, Schwemmle M. 2007. Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res 6:672-682. http://dx.doi.org/10.1021/pr060432u.
55. Plotch SJ, Bouloy M, Ulmanen I, Krug RM. 1981. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viralRNAtranscription. Cell 23:847-858. http://dx.doi.org/10.1016/0092-8674(81)90449-9.
56. Huarte M, Sanz-Ezquerro JJ, Roncal F, Ortin J, Nieto A. 2001. PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol 75:8597-8604. http://dx.doi.org/10.1128/JVI.75.18.8597-8604.2001.
57. Rodriguez A, Perez-Gonzalez A, Nieto A. 2011. Cellular human CLE/C14orf166 protein interacts with influenza virus polymerase and is required for viral replication. J Virol 85:12062-12066. http://dx.doi.org/10.1128/JVI.00684-11.
58. Mortillaro MJ, Blencowe BJ, Wei X, Nakayasu H, Du L, Warren SL, Sharp PA, Berezney R. 1996. A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc Natl Acad Sci U S A 93:8253-8257. http://dx.doi.org/10.1073/pnas.93.16.8253.